SCHEMBL3448105

SCHEMBL3448105

NC(=O)[C@H]1[CH]CCN1C(=O)CNc1ccc(-n2ccccc2=O)cc1

nearest known ligand 0.38

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
SYK P43405 1/20 0.38
F10 P00742 17/20 0.36
ITGB1 P05556 1/20 0.34
ITGA4 P13612 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3448108 0.75 KDM1A (0.49) SYKF10
SCHEMBL8268510 0.70 F10 (0.43) SYKF10
SCHEMBL4694576 0.70 F10 (0.45) SYKF10ITGB1ITGA4
SCHEMBL4692509 0.69 F10 (0.39) SYKF10ITGB1ITGA4
SCHEMBL27853866 0.69 F10 (0.43) F10ITGB1ITGA4
SCHEMBL4691466 0.68 F10 (0.45) SYKF10ITGB1ITGA4
SCHEMBL4687743 0.67 F10 (0.42) SYKF10
SCHEMBL5436164 0.67 F10 (0.51) F10
SCHEMBL3448754 0.66 F10 (0.50) F10
SCHEMBL3451533 0.66 F10 (0.50) F10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7820699-B2 Cyclic amines HOFFMANN-LA ROCHE INC. (US) 2010-10-26 US disclosed
EP-1877404-A2 NOVEL CYCLIC AMINES F. Hoffmann-Roche AG (CH) 2008-01-16 EP disclosed
WO-2006114401-A2 NOVEL CYCLIC AMINES F. HOFFMANN-LA ROCHE AG (CH) 2006-11-02 WO disclosed
US-20060247238-A1 Cyclic amines F. HOFFMANN-LA ROCHE AG (CH) 2006-11-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060247238-A1 Cyclic amines F12, F11, F2 SYK 777/4885F10 4/4885ITGB1 1463/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.